Skip to content
MarketScale
‹ Back to IndustriesSciences

Richard Branson Reflects on Being in Space, What it Means for Virgin Galactic’s Future

Virgin Galactic completed a successful test flight to space last weekend, signaling a massive jump in the space tourism market. On board was none other than Virgin Founder Sir Richard Branson himself. Tune in below to see his thoughts on being a passenger on the vessel and what it means for the future of the…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · BloombergOuter SpaceRichard BransonSpace Tourism
Share

Key takeaways

01

Virgin Galactic completed a successful test flight to space last weekend, signaling a massive jump in the space tourism market.

02

On board was none other than Virgin Founder Sir Richard Branson himself.

03

Tune in below to see his thoughts on being a passenger on the vessel and what it means for the future of the…

Virgin Galactic completed a successful test flight to space last weekend, signaling a massive jump in the space tourism market. On board was none other than Virgin Founder Sir Richard Branson himself. Tune in below to see his thoughts on being a passenger on the vessel and what it means for the future of the company and space travel as a whole.

Branson: I’d been practicing some words to say to kids down on Earth for some time, and once I’m on it, once I’d done those words, just being able to unbuckle and then just take off and look out these massive windows, then the spaceship was upside down and taken the Earth from space. It was that something I’ve dreamt of since I was a kid. And it was completely and utterly awesome. And I Yeah. You know, one of those dreams come true. And I still think that I’m going to wake up any minute. And it’s all a dream.

Host: You did touch back down. You said that the feeling of weightlessness is indescribable, but will you at least have an attempt for me?

Branson: Well, it’s just the most. And it is. It’s just I mean, it wasn’t just the sort of floating, but then looking at the other three beneath me, because you just floating as well. And then looking out through these gigantic windows back at this stunningly beautiful Earth below, you know, I mean, like pristine, pristine sky, the strength of the blues and the Blacks. And and I think we were in space. And I’ve know, I’ve never know, I’ve always sort of pictured what it was going to be like. I mean, you know, like the ride up there, the ride back. And I never realized that the whole experience is going to be so vivid.

Host: What does today symbolize for the company, and also for those children that were present earlier?

Branson: For the children we’ve just got to get building as many spaceships as we can as fast as we can. So that one that one day those kids will have the chance to have a similar experience or what I had and that we will do. We also launched this giant global raffle today. So that, you know, two kids, you know, just $10 for a pair of tickets. If they could win the raffle, they can go out. But that money will hopefully enable many, many people to be able to go up who could never have dreamt of going to space.

*Bloomberg contributed to this content

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Video TranscriptExpand ↓

I've been practicing some words to say to kids down on Earth for some time, and once I'm on it, once I'd done those words, just being able to unbuckle and then just take off and look out these massive windows, then the spaceship was upside down and taken the Earth from space. It was that something I've dreamt of since I was a kid. And it was completely and utterly awesome. And I Yeah. You know, one of those dreams come true. And I still think that I'm going to wake up any minute. And it's all a dream. It was just to your hair. You did touch back down. You said that the feeling of weightlessness is indescribable, but will you at least have an attempt for me? Well, it's just the most. And it is. It's just I mean, it wasn't just the sort of floating, but then looking at the other three beneath me, because you just floating as well. And then looking out through these gigantic windows back at this stunningly beautiful Earth below, you know, I mean, like pristine, pristine sky, the strength of the blues and the Blacks. And and I think we were in space. And I've know, I've never know, I've always sort of pictured what it was going to be like. I mean, you know, like the ride up there, the ride back. And I never realized that the whole experience is going to be so vivid and well beyond sort of the satisfaction of your own goal was being achieved. What does today symbolize for the company, and also for those children that were present earlier? And we've looked for the children. We've just got to get building as many spaceships as we can as fast as we can. So that one that one day those kids will have the chance to have a similar experience or what I had and that we will do. We also launched this giant global raffle today. So that, you know, two kids, you know, just $10 for a pair of tickets. If they could win the raffle, they can go out. But that money will hopefully enable many, many people to be able to go up who could never have dreamt of going to space.

About the author

S
Sciences

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences